Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04655599
Status:
TERMINATED
Last Update Posted:
2021-05-17
First Post:
2020-11-19
Brief Title:
Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
Sponsor:
Arena Pharmaceuticals
Organization:
Arena Pharmaceuticals
Organization Data
Organization:
Arena Pharmaceuticals
Class:
INDUSTRY
Study ID:
APD371-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arena Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None